Origin Therapeutics Holdings Inc.
Origin Therapeutics Holdings Inc.
Your view on ORIG.CN
Overview
What the company does, where it operates, and who runs it.
About Origin Therapeutics Holdings Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Michael Galego
- Headquarters
- CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Michael Galego
- Headquarters
- CA
Origin Therapeutics Holdings Inc., an investment issuer, primarily focuses on investments in the psychedelic industry in Canada. It plans to invests in the research, design, development, testing, production, distribution, and sale of psychedelics and related activities. The company was formerly known as 1278700 B.C. Ltd. Origin Therapeutics Holdings Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.